We are aware that the coronavirus (COVID-19) outbreak is putting sustained pressure on genomic testing services globally. EMQN has issued a statement on its impact on EQA timetables for 2020.
The EQA distributions planned for May and June 2020 have been postponed - please click the button below to see which schemes have been affected.
Manchester, UK, 6th March 2020: EMQN CIC today announced it is collaborating with GenQA to launch a pilot EQA scheme for HRR gene testing in patients with advanced Prostate Cancer.
Manchester, UK, 26th February 2020: EMQN CIC today announced it is collaborating with GenQA to launch an EQA Scheme for cfDNA testing for EGFR mutations in lung cancer.
Manchester, UK, 4th February 2020: EMQN CIC (“EMQN” or “the Company”), a global leader in external quality assessment (EQA) / proficiency testing (PT) for genomics, today announced it is launching a pilot EQA scheme for PIK3CA testing in patients with advanced or metastatic breast cancer.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
The latest news and press releases
Astrazeneca sponsor the cfDNA testing for EGFR mutations in Lung cancer EQA scheme. Click here (https://t.co/KsIUs4NxY7) to read more.
EQA distributions planned for May and June 2020 have been postponed - PLEASE READ - https://t.co/IaHQIxb83z
EQA distributions planned for May and June 2020 have been postponed. Distribution dates will be rescheduled for lat… https://t.co/w0oHz2Ph7D
Results of 2019 BRCA Ovarian EQA schemes published today. Please login to your EMQN account to view them.
Validated genotypes published for 2020 Germline EQA schemes - https://t.co/SYq6fDA7CF